Quality assurance of HDR prostate plans:
โ
Jennifer B. Rush; Michael D. Thomas
๐
Article
๐
2005
๐
Elsevier Science
๐
English
โ 150 KB
Adenocarcinoma of the prostate is currently the most commonly diagnosed cancer in men in the United States, and the second leading cause of cancer mortality. The utilization of radiation therapy is regarded as the definitive local therapy of choice for intermediate- and high-risk disease, in which t